Target intelligence / Profile preview

Caseinolytic peptidase X (ClpX)

Target
ClpX
Molecular classification
Enzyme, AAA+ ATPase, Molecular chaperone, Protease subunit
01

Overview

Caseinolytic peptidase X (ClpX) is a highly conserved AAA+ (ATPases Associated with diverse cellular Activities) ATPase that serves as a critical molecular chaperone and regulatory subunit within the ClpXP protease complex (UniProt, 2023). Its primary biological function involves the recognition, unfolding, and translocation of specific protein substrates into the proteolytic chamber of ClpP for degradation (Bhandari et al., 2018). This process is essential for maintaining bacterial proteostasis, managing stress responses, and regulating the cell cycle by degrading key proteins like FtsZ (Sass et al., 2011). In many pathogenic bacteria, such as Staphylococcus aureus and Mycobacterium tuberculosis, ClpX is indispensable for survival and virulence, making it an attractive target for the development of next-generation antibiotics (Gao et al., 2015). Pharmacological modulation of ClpX typically involves either the inhibition of its ATPase-driven unfolding activity or the disruption of its interaction with ClpP, which can lead to the accumulation of toxic protein aggregates or uncontrolled proteolysis (Brötz-Oesterhelt & Sass, 2014). While ClpX presents a high-value target for treating multi-drug resistant infections, drug design must ensure selectivity to avoid interfering with the human mitochondrial homolog, hClpX, which could lead to host toxicity (Kurat et al., 2017).

Other names
ATP-dependent Clp protease ATP-binding subunit ClpXClpX chaperoneAAA+ ATPase ClpXCaseinolytic protease X
02

Mechanism of action

Inhibition of ATPase activity and protein unfolding, or disruption of the ClpXP protease complex assembly to prevent regulated protein degradation; alternatively, some drugs (ADEPs) bind the associated ClpP core to displace ClpX and cause dysregulated proteolysis.

03

Biological functions

Protein unfoldingProtein degradationProteostasisStress responseRegulation of DNA replicationCell cycle regulation
04

Disease associations

InfectionBacterial infectionTuberculosisAntimicrobial resistance
05

Safety considerations

Mitochondrial toxicity due to homology with human mitochondrial ClpX (hClpX)Potential for rapid development of resistance in non-essential pathwaysOff-target effects on host proteostasis
06

Interacting drugs

Acyldepsipeptides (ADEPs)

3 more in the full profile.

07

Biomarkers

Bacterial loadFtsZ protein levelsClpP expression levels

Beyond the preview

Go deeper on Caseinolytic peptidase X (ClpX).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caseinolytic peptidase X (ClpX).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call